Blood pressure control by drug group in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

C Cushman, William; E Ford, Charles; T Einhorn, Paula; T Wright, Jackson; A Preston, Richard; R Davis, Barry; N Basile, Jan; K Whelton, Paul; J Weiss, Robert; Bastien, Arnaud; L Courtney, Donald; P Hamilton, Bruce; Kirchner, Kent; T Louis, Gail; M Retta, Tamrat; G Vidt, Donald; Collaborative Research Group, ALLHAT

doi:10.1111/j.1751-7176.2008.00015.x

Public

Blood pressure control by drug group in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Published in Journal of clinical hypertension (Greenwich, Conn.) • Oct 1, 2008

NobleIDark:/48914/w1/20260522/567573CARecord on NobleID

Authors:

William C Cushman

,

Charles E Ford

,

Paula T Einhorn

Abstract

Blood pressure (BP) control rates and number of antihypertensive medications were compared (average follow-up, 4.9 years) by randomized groups: chlorthalidone, 12.5-25 mg/d (n=15,255), amlodipine 2.5-10 mg/d (n=9048), or lisinopril 10-40 mg/d (n=9054) in a randomized double-blind hypertension trial....

Discussions